| 000 | 01704 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518050225.0 | ||
| 264 | 0 | _c20191209 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1524-4733 | ||
| 024 | 7 |
_a10.1016/j.jval.2018.11.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGorrod, Helen Bell | |
| 245 | 0 | 0 |
_aImpact of Nonrandomized Dropout on Treatment Switching Adjustment in the Relapsing-Remitting Multiple Sclerosis CLARITY Trial and the CLARITY Extension Study. _h[electronic resource] |
| 260 |
_bValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research _c07 2019 |
||
| 300 |
_a772-776 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCladribine _xadministration & dosage |
| 650 | 0 | 4 | _aConfounding Factors, Epidemiologic |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aModels, Statistical |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdiagnosis |
| 650 | 0 | 4 | _aPatient Dropouts |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLatimer, Nicholas R | |
| 700 | 1 | _aDamian, Doris | |
| 700 | 1 | _aHettle, Robert | |
| 700 | 1 | _aHarty, Gerard T | |
| 700 | 1 | _aWong, Schiffon L | |
| 773 | 0 |
_tValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research _gvol. 22 _gno. 7 _gp. 772-776 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jval.2018.11.015 _zAvailable from publisher's website |
| 999 |
_c29873901 _d29873901 |
||